Influence of allergy on the immunomodulatory and clinical effects of long-term low-dose macrolide treatment of nasal polyposis

Biomedical Papers

Volumn 154, Issue 4, 2010, Pages 327-334

  Perica, Aleksandar ^a   Vojvodicb, Danilo ^a   Baletica, Nenad ^a   Pericc, Aneta ^a   Miljanovicd, Olivera ^b  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b UNIVERSITY OF MONTENEGRO   (Montenegro)

Author keywords

Allergy; Clarithromycin; Cytokines; Il 8; Nasal fluid; Nasal polyposis

Indexed keywords

EID: 78650806135     PISSN: 12138118     EISSN: 12138118     Source Type: Journal    
DOI: 10.5507/bp.2010.049     Document Type: Article

References (25)

1. Norlander T, Brönnegård M, Stierna P. The relationship of nasal polyps, infection, and inflammation. Am J Rhinol 1999;13:349-55.
2. Pácová H, Kučera T, Astl J, Martínek J. Detection of beta-defensins and NOS in healthy and pathological nasal mucosa. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2004;148:239-40.
3. Nonaka M, Pawankar R, Saji F, Yagi T. Distinct expression of RANTES and GM-CSF by lipopolysaccharide in human nasal fibroblasts but not in other airway fibroblasts. Int Arch Allergy Immunol 1999;119:314-21.
4. Bonfils P, Avan P, Malinvaud D. Influence of allergy on the symptoms and treatment of nasal polyposis. Acta Otolaryngol 2006;126:839-44.
5. Riechelmann H, Deutschle T, Friemel E, Gross HJ, Bachem M. Biological markers in nasal secretions. Eur Respir J 2003;21:600-5.
6. Fokkens W, Lund V, Mullol J; European Position Paper on Rhinosinusitis and Nasal Polyps group. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 2007;45(Suppl 20):1-136.
7. Tsicopoulos A, Shimbara A, de Nadai P, Aldewachi O, Lamblin C, Lassalle P, et al. Involvement of IL-9 in the bronchial phenotype of patients with nasal polyposis. J Allergy Clin Immunol 2004;113:462-9.
8. Lildholdt T, Rundcrantz H, Bende M, Larsen K. Glucocorticoid treatment for nasal polyps: the use of topical budesonide powder, intramuscular betamethasone, and surgical treatment. Arch Otolaryngol Head Neck Surg 1997;123:595-600.
9. Bachert C, Van Kempen M, Van Cauwenberge P. Regulation of proinflammatory cytokines in seasonal allergic rhinitis. Int Arch Allergy Immunol 1999;118:375-9.
10. Perić A, Vojvodić D, Radulović V. Cytokine profiles in nasal fluid in patients with nasal polyps: a flow cytometric study. J Med Biochem 2010;29:28-33.
11. Ichimura K, Shimazaki Y, Ishibashi T, Higo R. Effect of new macrolide roxithromycin upon nasal polyps associated with chronic sinusitis. Auris Nasus Larynx 1996;23:48-56.
12. Yamada T, Fujieda S, Mori S, Yamamoto H, Saito H. Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol 2000;14:143-8.
13. Cervin A, Kalm O, Sandkull P, Lindberg S. One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effects on mucoliliary parameters and nasal nitric oxide. Otolaryngol Head Neck Surg 2002;126:481-9.
14. Haruna S, Shimada C, Ozawa M, Fukami S, Moriyama H. A study of poor responders for long-term, low-dose macrolide administration for chronic rhinosinusitis. Rhinology 2009;40:66-71.
15. Nonaka M, Pawankar R, Tomiyama S, Yagi T. A macrolide antibiotic, roxithromycin, inhibits the growth of nasal polyp fibroblasts. Am J Rhinol 1999;13:267-72.
16. Nonaka M, Pawankar R, Saji F, Yagi T. Effect of roxithromycin on IL-8 synthesis and proliferation of nasal polyp fibroblasts. Acta Otolaryngol Suppl 1998;539:71-5.
17. Kmoníčková E, Kutinová Canová N, Farghali H, Holý A, Zídek Z. Modulator of intracellular Ca 2+, thapsigarin, interferes with in vitro secretion of cytokines and nitric oxyde. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005;149:321-4.
18. Dordević V, Zvezdanović L, Ćosić V, Vlahović P, Kundalić S, Jevtović-Stoimenov T, et al. Serum levels and in vitro production of Th1- and Th2-type cytokines by peripheral blood mononuclear cells in patients suffering from systemic lupus erythematosus. J Med Biochem 2010;29:19-27.
19. Ohori J, Ushikai M, Sun D, Nishimoto K, Sagara Y, Fukuiwa T, et al. TNF-α upregulates VCAM-1 and NF-κB in fibroblasts from nasal polyps. Auris Nasus Larynx 2007;34:177-83.
20. Saji F, Nonaka M, Pawankar R. Expression of RANTES by IL-1β and TNF-α stimulated nasal polyp fibroblasts. Auris Nasus Larynx 2000;27:247-52.
21. Yoshifuku K, Matsune S, Ohori J, Sagara Y, Fukuiwa T, Kurono Y. IL-4 and TNF-α increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration. Rhinology 2007;45:235-41.
22. Iino Y, Toriyama M, Kudo K, Natori Y, Yuo A. Erythromycin inhibition of lipopolysaccharide-stimulatied tumor necrosis factor alpha production by human monocytes in vitro. Ann Otol Rhinol Laryngol Suppl 1992;101(suppl 157):16-20.
23. Xu G, Xia JH, Zhou H, Yu CZ, Zhang Y, Zuo KJ, et al. Interleukin-6 is essential for Staphylococcal exotoxin B-induced T regulatory cell insufficiency in nasal polyps. Clin Exp Allergy 2009;39:829-37.
24. Tokushige E, Itoh K, Ushikai M, Katahira S, Fukuda K. Localization of IL-1 beta mRNA and cell adhesion molecules in the maxillary sinus mucosa of patients with chronic sinusitis. Laryngoscope 1994;104:1245-50.
25. Miyanohara T, Ushikai M, Matsune S, Ueno K, Katahira S, Kurono Y. Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts. Laryngoscope 2000;110:126-31.